Author(s): Hiren R. Patel, Jatin Patel, I. S. Anand, C. N. Patel

Email(s): hircp_sspc@yahoo.com

DOI: Not Available

Address: Hiren R. Patel*, Jatin Patel, I. S. Anand and C. N. Patel
Dept. of Clinical Pharmacy, Shri Sarvajanik Pharmacy College, Near Arvind Baugh, Mehsana-384 001, India
*Corresponding Author

Published In:   Volume - 3,      Issue - 2,     Year - 2010


ABSTRACT:
Pacemaker is an object that influences the rate at which a certain phenomenon occurs, if it influences heart rate than is called cardiac pacemaker (natural or artificial cardiac pacemaker). The primary purpose of a pacemaker is to maintain an adequate heart rate, because either the heart's native pacemaker is not fast enough, or there is a block in the heart's electrical conduction system. Dr. Hopps invented first implantable artificial pacemaker in 1958. A patient's lifestyle is little bit modified. Few activities those are unwise such as full contact sports and activities that involve intense magnetic fields. Security and privacy concerns have been raised with pacemakers that allow wireless communication. Modern pacemakers are externally programmable and allow the cardiologist to select the optimum pacing modes for individual patients. Like, some combine a pacemaker and defibrillator in a single implantable device. Others have multiple electrodes stimulating differing positions within the heart to improve synchronization of the lower chambers of the heart. A Biventricular Pacemaker (BVP), also known as CRT (cardiac resynchronization therapy) by pacing both sides of the left ventricle, the pacemaker can resynchronize right atrium, right ventricle and left ventricle. An unrealized advancement in pacemaker function could mimic nature by utilizing various bodily input parameters such as CO2 - O2 level at in arterial-vein system, Body temperature, Respiratory rate, Body hormone levels like Adrenaline, etc. Advancement in design - as research efforts continue, future devices promise to be longer lasting, more reliable and versatile. Advances in battery technology, such as using radioactive isotopes, will undoubtedly improve the longevity of implanted pacemakers.


Cite this article:
Hiren R. Patel, Jatin Patel, I. S. Anand, C. N. Patel. Cardiac Pacemaker and Recent Advances. Research J. Pharm. and Tech. 3(2): April- June 2010; Page 390-398.

Cite(Electronic):
Hiren R. Patel, Jatin Patel, I. S. Anand, C. N. Patel. Cardiac Pacemaker and Recent Advances. Research J. Pharm. and Tech. 3(2): April- June 2010; Page 390-398.   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2010-3-2-70


REFERENCES:

1.       Lamas GA, Pashos CL, Normand ST, McNeil B. Permanent Pacemaker Selection and Subsequent Survival in Elderly Medicare Pacemaker Recipients. Circulation. 1995; 91:1063-9.

2.       Guidelines for implantation of cardiac pacemakers and antiarrhythmic devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation). Dreifus LS, Fisch C, Griffin JC, Gillette PC, Mason JW, Parsonnet V. Special report. Circulation. 1991; 84:455-67.

3.       Pacemakers, Patient and Public Information Center: Heart Rhythm Society available at http://www.hrspatients.org/patients/treatments/pacemakers.asp. (Assesd on  April 30, 2009).

4.       Mallela VS, Ilankumaran V, and Rao NS. Trends in Cardiac Pacemaker Batteries. In Pacing and Electrophysiol J. 2004; 4(4): 201-12.

5.       http://www.cardioassoc.com/patient_pgs/pacericd.asp. (Assessed on May 3, 2009).

6.       Fraser JD, Gillis AM, Irwin ME, et al. Guidelines for pacemaker follow-up in Canada: A consensus statement of the Canadian Working Group on Cardiac Pacing. The J of Canadian Cardiovas Soc. 2000; 16(3): 355-76.

7.       Babouri A, Hedjeidj A, Guendouz L. Experimental and theoretical investigation of implantable cardiac pacemaker exposed to low frequency magnetic field. J Clin Monit Comput. 2009; 23(2):63-73.

8.       MP3 Headphones Interfere With Implantable Defibrillators, Pacemakers - Beth Israel Deaconess Medical Center. www.bidmc.org. (Retrieved on 08 July, 2009).

9.       Testing of work environments for electromagnetic interference. PACE. 1992; 15(10): p 163-6.

10.     Naehle CP, Litt H, Lewalter T, Sommer T. Do we need pacemakers resistant to magnetic resonance imaging? Europace. 2006; 8:388.

11.     Roguin, A., Schwitter, J., Vahlhaus, C., Lombardi, M., Brugada, J., Vardas, P., Auricchio, A., Priori, S., Sommer, T. (2008). Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 10: 336-346.

12.     Pakhomov AG, Mathur SP, Doyle J, Stuck BE, Kiel JL, Murphy MR. Comparative effects of extremely high power microwave pulses and a brief CW irradiation on pacemaker function in isolated frog heart slices. Bioelectromagnetics. 2000 ;21(4): 245-54.

13.     European Pacemaker Patient Identification card available at http://www.xs4all.nl/~fbaart/aktueel/pm.pdf. (Assessed on August 16, 2009).

14.     Copperman Y, Zarfati D, Laniado S. The effect of metal detector gateways on implanted permanent pacemakers. Pacing Clin Electrophysiol 1988; 11:1386-138

15.     Daniel H; Thomas S, Benjamin H, Benjamin R, Shane S, Defend B, et al. "Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses" (PDF). IEEE Symposium on Security and Privacy.2008.

16.     http://www.righthealth.com/topic/Pacemaker_Battery/overview/adam20?fdid=Adamv2_007369. (Assessed on September 23, 2009)

17.     Cleland JG, Daubert JC, et al. "The effect of cardiac resynchronization on morbidity and mortality in heart failure". N. Engl. J. Med. 2005; 352 (15): p 1539–49.

18.     Bardy GH, Lee KL, Mark DB, et al. "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure". N. Engl. J. Med. 2005; 352 (3): p 225–37.

19.     Bristow M, Saxon L, Boehmer J, Krueger S, et al. "Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure". N Engl J Med. 2004; 350 (21): p 2140–50.

20.     Erdmann E, Freemantle N, et al. "The effect of cardiac resynchronization on morbidity and mortality in heart failure". N Engl J Med. 2005; 352 (15): p 1539–49.

21.     Wilkoff BL, Cook JR, Epstein AE, et al. "Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial". JAMA. 2002; 288 (24): p 3115–23.

22.     TV, Glotzer, AS. Hellkamp, J Zimmerman, MO Sweeney, R Yee, R Marinchak, et al. Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation. 2003; 107: 1614 - 9.

23.     S Furman. Rate-modulated pacing. Circulation. 1990; 82: 1081 - 94.

24.     Lau CP, Ward DE and Camm AJ. Single-chamber cardiac pacing with two forms of respiration-controlled rate-responsive pacemaker. Chest. 1989; 95; 352-8.

25.     HC Hughes, RR Brownlee, and GF Tyers. Two to three years of failure-free testing of a rechargeable pacemaker in experimental complete heart block. Circulation, 2008; 54: 263-6.

26.     Bilitch M, Lau FYK, Cosby RS. Recent Advances in Artificial Pacemakers. Calif Med. 1967; 107(2): p 164-70.

 

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available